Immune Boost Capital Invests in Orthrus Therapeutics to Advance Antigen-Specific Immune Tolerance for Autoimmune Disease
IBC Founding Principal Dr. Sai Nandi to join the Orthrus Board as an observer and serve on its Scientific Advisory Board LOS ANGELES, CA, UNITED STATES, October 20, 2026 /EINPresswire.com/ -- Immune Boost Capital (IBC), the venture investment arm of …